Hofseth BioCare ASA has announced the completion of a private placement of new shares, with tranche 2 subject to an extraordinary general meeting (EGM) approving the issuance. An EGM is scheduled for November 20th, with voting undertakings already secured. The company focuses on sustainable practices and upcycling salmon industry side streams into ingredients for human and pet health. Their products have shown various health benefits, leading to academic partnerships and patents. Additionally, HBC has spun out a biotech-focused company, AecorBio Inc., with programs targeting prostate cancer and ovarian cancer. HBC is listed on the Oslo Stock Exchange under ticker “HBC.”

Read more at GlobeNewswire: Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL